Article (Scientific journals)
Cangrelor for emergent carotid stenting during stroke thrombectomy: a comparative analysis versus glycoprotein IIb/IIIa inhibitors or aspirin monotherapy.
Pop, Raoul; Finitsis, Stephanos Nikolaos; Marnat, Gaultier et al.
2024In Journal of NeuroInterventional Surgery, p. 2024-022125
Peer Reviewed verified by ORBi
 

Files


Full Text
jnis-2024-022125.full.pdf
Author postprint (583.4 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Stenosis; Stent; Stroke; Thrombectomy; Surgery; Neurology (clinical)
Abstract :
[en] [en] BACKGROUND: Periprocedural antiplatelet treatment is a key determinant for the risk-benefit balance of emergent carotid artery stenting (eCAS) during stroke endovascular treatment (EVT). We aimed to assess the safety and efficacy profile of cangrelor compared with glycoprotein IIb/IIIa (GPIIb/IIIa) inhibitors or aspirin monotherapy. METHODS: Data were extracted from the Endovascular Treatment in Ischemic Stroke (ETIS) registry, a prospective nationwide observational registry of stroke EVT in France. Included patients were treated with eCAS for anterior circulation tandem lesions between January 2015 and June 2023 and received periprocedural treatment with cangrelor, GPIIb/IIIa inhibitors or aspirin monotherapy. The primary outcome was functional outcome at 90 days, assessed by the modified Rankin Scale (mRS). Secondary outcomes included intracranial recanalization, hemorrhagic transformation and carotid stent patency at day 1. RESULTS: Of the 1687 patients treated, 384 met the inclusion criteria: 91 received cangrelor, 77 received GPIIb/IIIa inhibitors and 216 aspirin monotherapy. Cangrelor was associated with a negative shift in the distribution of mRS scores compared with GPIIb/IIIa inhibitors (aOR 0.48, 95% CI 0.25 to 0.94, P=0.033). Compared with aspirin, cangrelor improved carotid stent patency at day 1 (aOR 4.00, 95% CI 1.19 to 14.29, P=0.025) but showed no significant differences in clinical outcomes. There were no differences in outcomes between full dose and low dose cangrelor. GPIIb/IIIa inhibitors demonstrated higher odds of functional independence (aOR 2.56, 95% CI 1.08 to 6.25, P=0.033) compared with aspirin. CONCLUSIONS: This registry-based study indicates a potential trend towards lower odds of favorable clinical outcomes with cangrelor treatment compared with GPIIb/IIIa inhibitors. However, these findings should be interpreted with caution due to potential selection bias and warrant further research for validation.
Disciplines :
Neurology
Author, co-author :
Pop, Raoul ;  Department of Interventional Neuroradiology, Strasbourg University Hospitals, Strasbourg, France pop.raoul@gmail.com ; Interventional Radiology, IHU Strasbourg, Strasbourg, France ; INSERM UMR_S1255, Etablissement Français du Sang, Strasbourg, France
Finitsis, Stephanos Nikolaos ;  Department of Neuroradiology, Aristotle University of Thessaloniki, Thessalonike, Greece
Marnat, Gaultier ;  Interventional and Diagnostic Neuroradiology, CHU Bordeaux GH Pellegrin, Bordeaux, France
Derraz, Imad ;  Neuroradiology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France
Cognard, Christophe ;  Diagnostic and Therapeutic Neuroradiology, CHU Toulouse, Toulouse, France
Calviere, Lionel;  Stroke Unit, CHU Toulouse, Toulouse, France
Caroff, Jildaz ;  Department of Interventional Neuroradiology - NEURI Brain Vascular Center, Bicêtre Hospital, APHP, Le Kremlin Bicêtre, France
Clarençon, Frédéric;  Radiology, Sorbonne Universite, Paris, France ; Neuroradiology, Hopital Universitaire Pitie-Salpetriere, Paris, France
Delvoye, François  ;  Université de Liège - ULiège > Département des sciences cliniques ; Neurointerventional Radiology, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France
Consoli, Arturo ;  Diagnostic and Interventional Neuroradiology, Hospital Foch, Suresnes, France
Lapergue, Bertrand;  Neurology, Hospital Foch, Suresnes, France
Gory, Benjamin;  Department of Diagnostic and Interventional Neuroradiology, Centre Hospitalier Universitaire de Nancy, Nancy, France ; Radiology, Université de Lorraine, Nancy, France ; IADI, INSERM U1254, Nancy, France
ETIS Registry Investigators
More authors (3 more) Less
Language :
English
Title :
Cangrelor for emergent carotid stenting during stroke thrombectomy: a comparative analysis versus glycoprotein IIb/IIIa inhibitors or aspirin monotherapy.
Publication date :
06 September 2024
Journal title :
Journal of NeuroInterventional Surgery
ISSN :
1759-8478
eISSN :
1759-8486
Publisher :
BMJ Publishing Group, England
Pages :
jnis-2024-022125
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 25 November 2024

Statistics


Number of views
19 (1 by ULiège)
Number of downloads
0 (0 by ULiège)

Scopus citations®
 
0
Scopus citations®
without self-citations
0
OpenCitations
 
0
OpenAlex citations
 
0

Bibliography


Similar publications



Contact ORBi